US Patent Issued to Vanda Pharmaceuticals on Sept. 8 for "Methods of treating multiple sclerosis" (Canadian, American Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,116, issued on Sept. 8, was assigned to Vanda Pharmaceuticals Inc. (Washington).

"Methods of treating multiple sclerosis" was invented by Allitia DiBernardo (Philadelphia) and Maria Ait-Tihyaty (Montreal).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to methods of treating multiple sclerosis. In certain aspects, methods of treating early-stage multiple sclerosis in a patient are disclosed."

The patent was filed on Oct. 10, 2022, under Application No. 17/962,679.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPT...